Gene · 28402
Papers3,091
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,091
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clonal relatedness as a prognostic marker in Richter transformation of chronic lymphocytic leukemia: a systematic review. | Blood Adv | 2025 | 40127387 | PubTator, text mining | PubMed |
| Unusual traits shape the architecture of the Ig ancestor molecule. | Commun Biol | 2025 | 40113983 | PubTator, text mining | PubMed |
Impact of biological and genetic features of leukemic cells on the occurrence of "shark fins" in the WPC channel scattergrams of the Sysmex XN hematology analyzers in patients with chronic lymphocytic leukemia. | Clin Chem Lab Med | 2025 | 40084841 | PubTator, text mining | PubMed |
| Targeting the Immune Microenvironment in Chronic Lymphocytic Leukemia: An Evolving Therapeutic Strategy. | Eur J Haematol | 2025 | 40066747 | PubTator, text mining | PubMed |
| A Case of Primary Cutaneous T-Follicular Helper Cell Lymphoma, Follicular-Type. | Pathol Int | 2025 | 40062644 | PubTator, text mining | PubMed |
| Composite mantle cell lymphoma with cryptic ins(11;2)(q13;p11.2p11.2)/IGK::CCND1 and lymphoplasmacytic lymphoma with MYD88 L265P mutation. | Cancer Genet | 2025 | 40058168 | PubTator, text mining | PubMed |
| Deep sequencing of BCR heavy chain repertoires in myalgic encephalomyelitis/chronic fatigue syndrome. | Front Immunol | 2025 | 40034707 | PubTator, text mining | PubMed |
| Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia. | N Engl J Med | 2025 | 39976417 | PubTator, text mining | PubMed |
| Real world outcomes with Ibrutinib monotherapy in chronic lymphocytic leukemia: a single center experience. | Med Pharm Rep | 2025 | 39949913 | PubTator, text mining | PubMed |
| Normal Residual Lymphoid Cell Populations in Blood as Surrogate Biomarker of the Leukemia Cell Kinetics in CLL BinetA/Rai 0. | Cancers (Basel) | 2025 | 39941719 | PubTator, text mining | PubMed |
| High Expression Levels of the Long Non-Coding RNAs Lnc-IRF2-3 and Lnc-KIAA1755-4 Are Markers of Poor Prognosis in Chronic Lymphocytic Leukemia. | Int J Mol Sci | 2025 | 39940921 | PubTator, text mining | PubMed |
| MRD-guided zanubrutinib, venetoclax, and obinutuzumab in relapsed CLL: primary end point analysis from the CLL2-BZAG trial. | Blood | 2025 | 39883943 | PubTator, text mining | PubMed |
| Back from (BTKi) holiday. | Blood Adv | 2025 | 39808448 | PubTator, text mining | PubMed |
| BiomiX, a user-friendly bioinformatic tool for democratized analysis and integration of multiomics data. | BMC Bioinformatics | 2025 | 39794699 | PubTator, text mining | PubMed |
| Prognostic factors in chronic lymphocytic leukaemia - the old, the new and the future. | Leuk Lymphoma | 2025 | 39773307 | PubTator, text mining | PubMed |
| Immunoglobulin light chain mutational status refines IGHV prognostic value in identifying chronic lymphocytic leukemia patients with early treatment requirement. | Leukemia | 2025 | 39690182 | PubTator, text mining | PubMed |
| Single-cell analysis of a bi-clonal chronic lymphocytic leukemia reveals two clones with distinct gene expression pattern. | Leuk Lymphoma | 2025 | 39689719 | PubTator, text mining | PubMed |
| SOHO State of the Art Updates and Next Questions | Impact of Biologic Markers on Outcomes With Novel Therapy in Chronic Lymphocytic Leukaemia. | Clin Lymphoma Myeloma Leuk | 2025 | 39674706 | PubTator, text mining | PubMed |
| JNK1 inhibitors target distal B cell receptor signaling and overcome BTK-inhibitor resistance in CLL. | J Exp Med | 2025 | 39570282 | PubTator, text mining | PubMed |
| Comparing the efficacy and safety of first-line treatments for chronic lymphocytic leukemia: a network meta-analysis. | J Natl Cancer Inst | 2025 | 39392788 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28402/papers?page=8